ACTIVE

DEVGEN

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result2,9 M €-35,7 %over 1 year
Revenue1,1 M €+19,6 %over 1 year
Equity128,3 M €+2,3 %over 1 year
Workforce2,9 ETP-14,7 %over 1 year

Identity

Source · BCE/KBO

DEVGEN is a Public limited company incorporated in 1997. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 2,9 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0461.432.562
Incorporation
11/09/1997
Legal form
Public limited company
Registered office
Technologiepark-Zwijnaarde 30
9052 Gent · FlandreSee on map
Contributed capital
135 599 547,70 €
Latest accounts
31/12/2025
Average workforce
2,9 ETP
Joint committees (2)
  • 116
  • 207
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

Financials

Source · NBB, 34 filings

Trend over 12 financial years

20252024202320222021
Income statement
Revenue1,1 M €944,2 k €10,6 M €6,3 M €6,8 M €
EBITDA80,3 k €63,5 k €7,8 M €899,7 k €3,3 M €
Operating result70,1 k €53,3 k €7,3 M €407 k €2,9 M €
Net result2,9 M €4,6 M €9,1 M €239,1 k €2,9 M €
Balance sheet
Equity128,3 M €125,4 M €120,8 M €111,7 M €111,4 M €
Total assets130,9 M €130,1 M €126,4 M €113,7 M €114,5 M €
Cash–––––
Debts2,6 M €4,7 M €5,6 M €2 M €3 M €
Other
Workforce2,9 ETP3,4 ETP17,0 ETP28,9 ETP30,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 43 ended

Active mandates

Johan De Dobbelaere

Director · since 30 septembre 2023 · until 29 septembre 2029

Active
Caroline Dierickx

Director · since 30 juin 2020 · until 30 juin 2026

Active
Richard Peletier

Director · since 25 mai 2020 · until 24 mai 2026

Active

Ended mandates

Sabine Drieghe

Director · since 30 juin 2020 · until 06 avril 2023

Ended
Sabine Drieghe

Director · since 30 juin 2020 · until 30 juin 2026

Ended
Richard Peletier

Director · since 26 mai 2020 · until 30 juin 2026

Ended
Wendy Maddelein

Director · since 26 mai 2020 · until 30 septembre 2023

Ended

Other companies at this address

Technologiepark-Zwijnaarde 30 9052 Gent
CompanyCBE no.
Confo Therapeutics● Active
0632.474.939
Eastman Chemical Technology● Active
0671.793.393
Syngenta Seeds● Active
0404.599.569

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date20/07/202611/07/202509/07/202409/07/202409/07/202409/07/2024
General meeting30/06/202626/06/202525/06/202427/06/202330/06/202229/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 34 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202530/06/202620/07/2026DutchPDF
Full model31/12/202426/06/202511/07/2025DutchPDF
Full model31/12/202325/06/202409/07/2024DutchPDF
Full modelCorrection31/12/202227/06/202309/07/2024DutchPDF
Full model31/12/202227/06/202324/10/2023DutchPDF
Full modelCorrection31/12/202130/06/202209/07/2024DutchPDF
Full model31/12/202130/06/202224/07/2023DutchPDF
Full modelCorrection31/12/202029/06/202109/07/2024DutchPDF
Full modelCorrection31/12/202029/06/202125/07/2023DutchPDF
Full modelCorrection31/12/202029/06/202103/03/2023DutchPDF
Full model31/12/202029/06/202130/03/2022DutchPDF
Full modelCorrection31/12/201930/06/202024/04/2021DutchPDF
Full model31/12/201930/06/202021/02/2021DutchPDF
Full model31/12/201825/06/201930/11/2019DutchPDF
Full model31/12/201726/06/201824/07/2018DutchPDF
Full model31/12/201627/06/201723/11/2017DutchPDF
Full model31/12/201528/06/201610/07/2016DutchPDF
Full modelCorrection31/12/201429/06/201514/07/2015DutchPDF
Full model31/12/201429/06/201530/06/2015DutchPDF
Full model31/12/201327/06/201416/07/2014DutchPDF
Full model31/12/201212/07/201323/07/2013DutchPDF
Consolidated accounts31/12/201223/04/201324/03/2014DutchPDF
Full model31/12/201101/06/201227/06/2012DutchPDF
Consolidated accounts31/12/201101/06/201228/06/2012DutchPDF
Full model31/12/201001/06/201112/07/2011DutchPDF
Consolidated accounts31/12/201001/06/201107/07/2011DutchPDF
Full model31/12/200901/06/201009/06/2010DutchPDF
Consolidated accounts31/12/200901/06/201022/06/2010DutchPDF
Full model31/12/200802/06/200929/06/2009DutchPDF
Consolidated accounts31/12/200802/06/200929/06/2009DutchPDF
Full model31/12/200702/06/200820/06/2008DutchPDF
Consolidated accounts31/12/200702/06/200820/06/2008DutchPDF
Full model31/12/200601/06/200713/06/2007DutchPDF
Consolidated accounts31/12/200601/01/999926/07/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 43 ended

Active mandates

Johan De Dobbelaere

Director · since 30 septembre 2023 · until 29 septembre 2029

Active
Caroline Dierickx

Director · since 30 juin 2020 · until 30 juin 2026

Active
Richard Peletier

Director · since 25 mai 2020 · until 24 mai 2026

Active

Ended mandates

Sabine Drieghe

Director · since 30 juin 2020 · until 06 avril 2023

Ended
Sabine Drieghe

Director · since 30 juin 2020 · until 30 juin 2026

Ended
Richard Peletier

Director · since 26 mai 2020 · until 30 juin 2026

Ended
Wendy Maddelein

Director · since 26 mai 2020 · until 30 septembre 2023

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates13/07/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/06/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates18/09/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/01/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - DIVERSEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates27/11/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/09/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/05/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates03/11/2020
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20252,9 M €↓
  2. 2024
    Annual accounts 20244,6 M €↓
  3. 18/09/2024
    nominationMike Boonen — vaste vertegenwoordiger
  4. 17/06/2024
    autre
  5. 2023
    Annual accounts 20239,1 M €↑
  6. 27/06/2023
    nominationKPMG Bedrijfsrevisoren BV/SRL — commissaris
  7. 27/06/2023
    nominationHenk Vandorpe — vaste vertegenwoordiger
  8. 2022
    Annual accounts 2022239,1 k €↓
  9. 2021
    Annual accounts 20212,9 M €↑
  10. 2020
    Annual accounts 2020356,7 k €↓
  11. 2015
    Annual accounts 2015689,2 k €↓
  12. 2014
    Annual accounts 201445,7 M €↑
  13. 2009
    Annual accounts 2009-6,4 M €↑
  14. 2008
    Annual accounts 2008-23,3 M €↓
  15. 2007
    Annual accounts 2007-12,4 M €↓
  16. 2006
    Annual accounts 2006-8,6 M €
  17. 11/09/1997
    IncorporationPublic limited company